Research Notes

Philip Morris International enters its October 21 update with strong smoke-free growth, soft U.S. results and a demanding proof point for execution.

Hasbro enters its October 20 update with Wizards momentum, improving Consumer Products revenue and a key question about the breadth of profit.

Cleveland-Cliffs shows stronger operating momentum, while leverage, contract timing and the October update keep the durability question open.

Marsh’s October 15 update will test whether steady underlying growth can translate into stronger margins across risk services and consulting.

Domino’s Pizza enters its October 13 update with order growth, mixed margins and a balance sheet that keeps cash conversion and leverage in focus.

Albertsons approaches its October 13 update with digital and pharmacy growth set against lower identical sales and continuing first-quarter margin pressure.

Semtech approaches its October 15 Analyst Day with accelerating sales, improving margins and a durability question that completed results must answer.

RXO enters a signed merger process with C.H. Robinson, where floating stock consideration and pending approvals keep the outcome evidence-dependent.

PTC has a signed all-cash agreement and committed financing, but shareholder approval, regulatory reviews, and a long timetable keep the outcome open.

Vaxcyte’s positive OPUS-1 result reduced clinical uncertainty, while follow-on studies, manufacturing, and review still shape commercial value.